- Drug commonly used to treat HER2-positive breast cancer sees tumour shrinkage in several other cancer types.
- Cancer treatment combination may have more uses than previously thought.
- Home
- Research & Innovation
- News
- College Team
- Programmes
- Hospital Partners
- Community Partners
- Jennings Gallery
- Graduate Studies
- Programmes for International (Non-EU) Students
- Interprofessional Learning (IPL)
- ASSERT
- Dr Ashleigh Byrne-O’Brien Memorial Fund
- iEd Hub
- Inaugural Professorial Lecture Series
- Learning, Teaching & Curriculum
- Philanthropic Lectures
- UCC Academic Health Sciences
- Continuing Professional Development
Our stories of impact
-
New study reveals breast cancer drug combination has impact on other cancers
04 Mar 2024 -
UCC researchers find no immediate increase in rates of suicide globally during the first 15 months of the Covid-19 pandemic
28 Feb 2024- Review finds no increase in suicide rate during the Covid-19 pandemic.
- A range of factors during the pandemic served as protective effects to the risk of suicide.
- Study also highlights the need for high-quality and timely data on suicide deaths worldwide.
-
New three-drug combination treatment achieves notable responses in patients with advanced HER2-negative breast cancer
15 Feb 2024Treatment in a recent study combined a histone deacetylase (HDAC) inhibitor - a drug that causes a chemical change to stop tumor cells from dividing - with two types of immunotherapy known as checkpoint inhibitors, which unharness the power of the immune response against cancer.
Read more -
UCC researchers find that people with COPD see improved health benefits from lifestyle changes
13 Feb 2024- Research shows that people with the complex lung disease COPD see improved health benefits from behaviour change interventions.
- It is estimated that over 380,000 people in Ireland suffer from COPD.
- Interventions ‘has helped me greatly’ says woman with COPD.
-
Researchers develop new prediction tool to identify cognitive impairment
11 Jan 2024Impaired cognition among preterm infants can be predicted prior to discharge from neonatal care, new joint Irish and Swedish research shows.
Read more -
The College of Medicine and Health at UCC Innovation Week 2025
07 Apr 2025SEFS/CoMH/Tyndall Innovation and Commercialisation Showcase
Read more -
College of Medicine and Health Annual Research Conference Showcases Innovation and Partnership
08 Sep 2025The theme of the conference was 'Academic Health Sciences System.'
Read more